It's a big bet but this is much smaller relative to ALL's market cap and core business than the Quindell purchase. Which equals less risk in my book. Key management are also staying on after purchase, and some payment is performance linked over the 2 years in the case of Plarium and possibly Big Fish though this wasn't detailed. Slater and Gordon got no such protections and SGS was cash flow negative and a completely different business model, for example very labour intensive. There were also aggressive accounting practices obscuring the true performance of Quindell in the years before sale and during sale process. If these acquisitions don't perform it won't drain cash flow and bring the core down like SGH.
- Forums
- ASX - By Stock
- Great Acquisition
It's a big bet but this is much smaller relative to ALL's market...
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$66.49 |
Change
-1.120(1.66%) |
Mkt cap ! $36.16B |
Open | High | Low | Value | Volume |
$67.50 | $67.50 | $65.92 | $138.3M | 2.127M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 42920 | $66.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$66.51 | 2281 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11689 | 24.180 |
2 | 11791 | 24.170 |
1 | 20645 | 24.160 |
3 | 24239 | 24.150 |
3 | 41354 | 24.140 |
Price($) | Vol. | No. |
---|---|---|
24.220 | 11689 | 1 |
24.230 | 11731 | 1 |
24.240 | 26310 | 3 |
24.250 | 12545 | 2 |
24.260 | 16391 | 2 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
ALL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online